Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements.
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate whether previously reported benefit of Tranexamic
acid in pediatric orthopedic surgeries could be recapitulated in bone tumor surgeries or not
through a double blinded randomized controlled trial done in children cancer hospital 57357.